DrugInformations.org

St. Jude Medical, Inc. (NYSE:STJ) announced the first patient implants in a clinical study that is investigating whether deep brain stimulation (DBS) therapy will help people who suffer from major depressive disorder, a severe form of depression. The patients, a 59-year-old woman and a 42-year-old man, were implanted at Alexian Brothers Behavioral Health Hospital in Chicago, with the St. Jude Medical Libra® Deep Brain Stimulation System, an investigational device.

More: continued here

No Comments »

ST. PAUL, Minn. - June 26, 2008 - St. Jude Medical, Inc. (NYSE:STJ) today announced the first patient implants in a clinical study that is investigating whether deep brain stimulation (DBS) therapy will help people who suffer from major depressive disorder, a severe form of depression. The patients, a 59-year-old woman and a 42-year-old man, were implanted at Alexian Brothers Behavioral Health Hospital in Chicago, with the St.

More: continued here

No Comments »

A study suggests that a “smoldering” central nervous system (CNS) infection may play a role in conditions that plague millions of Americans. Kazuhiro Kondo, MD, PhD, of the Jikei University Medical School in Tokyo identified a novel human herpesvirus-6 (HHV-6) protein present in Chronic Fatigue Syndrome (CFS) patients but not healthy controls that may contribute to psychological symptoms often associated with that and other disorders.

More: continued here

No Comments »

New figures released by the Japanese authorities this week show that the country’s suicide rate is still climbing despite government efforts to dramatically reduce the figure by 2016, and the fastest rise appears to be among elderly Japanese, a growing sector of the population that is also experiencing rising poverty.

More: continued here

No Comments »

Chronic obstructive pulmonary disease (COPD) causes limitation of airflow in the lungs that cannot be fully reversed, leading to symptoms of breathlessness, cough, wheeze and sputum production. The disease, although chronic, is interspersed with periods of acute symptomatic and functional deterioration known as exacerbations. Exacerbations have important consequences for patients and their healthcare providers.

More: continued here

No Comments »

UT Southwestern Medical Center psychiatry researchers have taken what they learned from their groundbreaking research on treating depression and are applying it to real-world clinical settings.The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study was the largest ever on the treatment of major depressive disorder and is considered a benchmark in the field of depression research.

More: continued here

No Comments »

Primary care has the lead role in easing the burden of common mental disorders in Australia, according to an editorial in the supplement to the latest issue of the Medical Journal of Australia. The MJA’s 48-page supplement, funded by a grant from beyondblue: the national depression initiative, adds to the evidence base needed to achieve it.

More: continued here

No Comments »

A new study in JAMA finds that people who aretreated for type 2 diabetes have higher incidence rates of elevateddepressive symptoms. In the same article, researchers report a modestassociation between the risk of diabetes and persons with depression.It is known that compared to the general population, people withdiabetes are more likely to have elevated depressive symptoms andhigher rates of clinical depression.

More: continued here

No Comments »

Health minister Ivan Lewis announced the 32 sites who will begin to roll out talking therapies around the country. Each of the 32 Primary Care Trusts (PCTs) will receive a share of the £33 million first instalment of new money announced for the purpose by Health Secretary Alan Johnson on World Mental Health Day last year (10 October).

More: continued here

No Comments »

Researchers have long known that type-2 diabetes and depression often go hand in hand. However, it’s been unclear which condition develops first in patients who end up with both. Now, a new study led by Johns Hopkins doctors suggests that this chicken-and-egg problem has a dual answer: Patients with depression have an increased risk of developing type-2 diabetes, and patients with type-2 diabetes have an increased risk of developing depression.

More: continued here

No Comments »